株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

重水素化製剤治療の市場戦略

Deuterated Drugs Formulations Therapeutics Markets Strategies

発行 Greystone Research Associates 商品コード 539022
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
重水素化製剤治療の市場戦略 Deuterated Drugs Formulations Therapeutics Markets Strategies
出版日: 2017年08月07日 ページ情報: 英文
概要

当レポートでは、重水素化製剤治療の市場について調査し、現在FDAの認可を受けた、または後期開発段階にある重水素化製剤、その特徴、上市の経緯、および治療特徴、重水素化製剤の開発を促進する主な要因、重水素化製剤ディベロッパーの製品戦略、現在の市場規模および主要企業などについて、分析しています。

エグゼクティブサマリー

重水素化製剤治療

  • 製剤設計技術
  • 薬剤特徴
  • 投与間隔の拡張
  • 治療薬のアンメットニーズに対応

主な短期的治療目標

  • 神経伝達物質の調整
  • 膜コンダクタンス
  • キナーゼ阻害薬
  • 抗炎症薬
  • ミトコンドリア機能制御
  • 抗新生物薬

重水素化製剤:短期的な治療市場の分析

  • 中国
  • 自己免疫疾患
  • 遺伝性疾患
  • 神経性疾患
  • 眼科疾患

市場要因

  • 規制・認可
  • 治験 & エンドポイント
  • IP/特許要因
  • 防衛的な特許戦略
  • 医療経済学

企業プロファイル

目次
Product Code: DTR354K

Deuterated Drugs: Products, Pipelines, Strategies, Therapeutics and Markets is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug formulation developers, product designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for drugs that incorporate deuterium into the chemical structure of APIs to modify drug properties in vivo. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Deuterated Drugs - What You Will Learn

  • What deuterated drugs are currently FDA-approved or in late-stage development, what are their distinguishing properties, how are they marketed, and what are the therapeutic specifics?
  • What are the major factors driving the development of deuterated drugs?
  • What are the product strategies of deuterated drug developers?
  • What is the size of the deuterated drug market today, who are the active sector participants, and what will the market look like in 2024?
  • How important are formulator-developer-manufacturer relationships and what are the key alliances in the industry?
  • What are the significant economic, technology, and regulatory factors affecting the market for deuterated drugs?

Table of Contents

Executive Summary

  • Drug Therapy Market Dynamics
  • Market Segments and Indications
  • Competing Technologies
  • Market Drivers
  • Drug Re-positioning/Re-purposing
  • Extending Patent Life
  • Dosing Frequency & Patient Adherence
  • Competitive Landscape
  • Formulators/Developers
  • Marketers
  • Alliances
  • Acquisitions

Deuterated Drug Therapeutics

  • Formulation Technology
  • Drug Property Kinetics
  • Extending Dosing Intervals
  • Addressing Unmet Therapeutic Needs

Selected Near-term Therapeutic Targets

  • Neurotransmitter Regulation
  • Transmembrane Conductance
  • Kinase Inhibitors
  • Anti-inflammatory
  • Mitochondrial Function Modulation
  • Antineoplastic

Deuterated Drugs - Near-term Therapeutic Market Analysis

  • Addiction
  • Autoimmune Diseases
  • Hereditary
  • Neurology
  • Oncology
  • Ophthalmology

Market Factors

  • Regulations and Approvals
  • Clinical Trials & End Points
  • IP/Patent Factors
  • Defensive Patent Strategies
  • Healthcare Economics

Company Profiles

Back to Top